Kalogeropoulos AS, Kennon S, Karamasis GV, Smith EJ, Rees P Successful Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction During Resuscitation From Cardiac Arrest by Combined Mechanical Chest Compressions and Intra-aortic Balloon Pump Counterpulsation: A Case Report. A A Pract. 2018 Jun 15;10(12):323-326. doi: 10.1213/XAA.0000000000000707.
Levis A, Greif R, Hautz WE, Lehmann LE, Hunziker L, Fehr T, Haenggi M Resuscitative endovascular balloon occlusion of the aorta (REBOA) during cardiopulmonary resuscitation: A pilot study. Resuscitation. 2020 Nov;156:27-34. doi: 10.1016/j.resuscitation.2020.08.118. Epub 2020 Aug 29.
Moriwaki Y, Tahara Y, Kosuge T, Suzuki N Etiology of out-of-hospital cardiac arrest diagnosed via detailed examinations including perimortem computed tomography. J Emerg Trauma Shock. 2013 Apr;6(2):87-94. doi: 10.4103/0974-2700.110752.
Osborn LA, Brenner ML, Prater SJ, Moore LJ Resuscitative endovascular balloon occlusion of the aorta: current evidence. Open Access Emerg Med. 2019 Jan 14;11:29-38. doi: 10.2147/OAEM.S166087. eCollection 2019.
Tang W, Weil MH, Noc M, Sun S, Gazmuri RJ, Bisera J Augmented efficacy of external CPR by intermittent occlusion of the ascending aorta. Circulation. 1993 Oct;88(4 Pt 1):1916-21. doi: 10.1161/01.cir.88.4.1916.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
